These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7856275)

  • 21. Are ACE inhibitors cardioprotective? ACE inhibitors improve cardiac function.
    Mitha AS; Wisenbaugh T
    S Afr Med J; 1991 Sep; 80(5):suppl 21-3; discussion suppl 24. PubMed ID: 1887340
    [No Abstract]   [Full Text] [Related]  

  • 22. Advantages of renin-angiotensin system blockade in the treatment of cardiovascular diseases.
    Gerc V; Buksa M
    Med Arh; 2010; 64(5):295-9. PubMed ID: 21287956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The renin-angiotensin system in hypertension and heart insufficiency: current aspects in the use of ACE inhibitors].
    Greminger P; Vetter W
    Schweiz Rundsch Med Prax; 1988 Jun; 77(24):673-9. PubMed ID: 3041532
    [No Abstract]   [Full Text] [Related]  

  • 24. Angiotensin and the Heart. Symposium proceedings. Hamburg, October 22-24, 1992.
    Basic Res Cardiol; 1993; 88 Suppl 1():1-222. PubMed ID: 8102846
    [No Abstract]   [Full Text] [Related]  

  • 25. Reinventing the ACE inhibitors: some old and new implications of ACE inhibition.
    Hanif K; Bid HK; Konwar R
    Hypertens Res; 2010 Jan; 33(1):11-21. PubMed ID: 19911001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [ACE inhibition in tissues. Decisive for prognosis?].
    MMW Fortschr Med; 2002 Mar; 144(11):60. PubMed ID: 12066521
    [No Abstract]   [Full Text] [Related]  

  • 27. The place of angiotensin-converting enzyme inhibition in the treatment of cardiovascular diseases.
    Gavras H
    N Engl J Med; 1988 Dec; 319(23):1541-3. PubMed ID: 3185679
    [No Abstract]   [Full Text] [Related]  

  • 28. ACE inhibitors as cardioprotective agents.
    Young JB
    Am J Manag Care; 2002 Jun; 8(9 Suppl):30-7. PubMed ID: 12099326
    [No Abstract]   [Full Text] [Related]  

  • 29. Not just numbers, but years of science: putting the ACE inhibitor-ARB meta-analyses into context.
    Ferrari R; Rosano GM
    Int J Cardiol; 2013 Jun; 166(2):286-8. PubMed ID: 23452882
    [No Abstract]   [Full Text] [Related]  

  • 30. The role of angiotensin-converting enzyme inhibitors in the therapy of cardiovascular disease: an overview.
    Chobanian A
    Angiology; 1989 Apr; 40(4 Pt 2):331-4. PubMed ID: 2705642
    [No Abstract]   [Full Text] [Related]  

  • 31. Angiotensin-converting enzyme inhibitors for the prevention and treatment of cardiovascular disease.
    Frishman WH
    Heart Dis; 2000; 2(3):183-4. PubMed ID: 11794142
    [No Abstract]   [Full Text] [Related]  

  • 32. ACE inhibition in cardiovascular disease.
    Francis GS
    N Engl J Med; 2000 Jan; 342(3):201-2. PubMed ID: 10639547
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of ACE inhibitor in cardiovascular disease.
    Nasution SA
    Acta Med Indones; 2006; 38(1):60-4. PubMed ID: 16479034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention].
    Ceconi C; Mastrorilli F; Squasi PA; Gaitani S; Guardigli G; Ferrari R
    Ital Heart J; 2005 Nov; 6 Suppl 7():5S-13S. PubMed ID: 16485512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Weber MA
    Am J Cardiol; 2007 Aug; 100(3A):45J-52J. PubMed ID: 17666198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ACE inhibition--prospects for the future. Satellite symposium to the XIIth Congress of the European Society of Cardiology. Stockholm, September 19, 1990.
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S1-49. PubMed ID: 1725195
    [No Abstract]   [Full Text] [Related]  

  • 37. Current indications for ACE inhibitors and HOPE for the future.
    Burch S; Ou N
    Am J Manag Care; 2002 May; 8(5):478-90; quiz 491-3. PubMed ID: 12019599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
    Borghi C; Cosentino E; De Sanctis D
    Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin receptor antagonists and ACE inhibitors.
    Howes LG; Christie N
    Aust Fam Physician; 1998 Oct; 27(10):914-7, 919-21. PubMed ID: 9798290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors.
    Weinberg MS; Weinberg AJ; Zappe DH
    J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):217-33. PubMed ID: 11881029
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.